Science & Tech
After COVID vaccines, time to use mRNA tech against other infectious diseases

After COVID Vaccines, Time to Use mRNA Tech Against Other Infectious Diseases | GZERO Media

Using mRNA technology to develop effective COVID vaccines has been a scientific breakthrough.
But that's just the tip of the iceberg, Melanie Saville, head of vaccine development at the Coalition for Epidemic Preparedness Innovations, said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill & Melinda Gates Foundation. "
There's still a lot that should be done with the technology moving forward" on other infectious diseases like HIV, malaria, or TB. Still, she said that vaccines are only the beginning.
Local manufacturing and distribution is as important — as is future equitable access to the mRNA tech itself.
The EU is having a moment; Norway, Iceland, Canada, and Britain are suddenly warming to Brussels, a reversal for a bloc that spent decades fighting off euroskeptics. As Norway's foreign minister put it, it's a "crazy world." And that's working in the EU's favor.
As America approaches its 250th anniversary, Bank of America is investing in the legacy of leadership — committing $5M to the Theodore Roosevelt Presidential Library and conserving 110 presidential portraits at the Smithsonian National Portrait Gallery, so the history of leaders who defined our nation is preserved for generations to come. Learn more here.
Chris, an Army veteran, started his Walmart journey over 25 years ago as an hourly associate. Today, he manages a Distribution Center and serves as a mentor, helping others navigate their own paths to success. At Walmart, associates have the opportunity to take advantage of the pathways, perks, and pay that come with the job — with or without a college degree. In fact, more than 75% of Walmart management started as hourly associates. Learn more about how over 130,000 associates were promoted into roles of greater responsibility and higher pay in FY25.
In this "ask ian," Ian Bremmer breaks down President Trump’s approach to the 2026 midterm elections and what his political strategy may look like afterward.